Skip to main content
Erschienen in: European Journal of Epidemiology 3/2016

Open Access 11.03.2016 | NEURO-EPIDEMIOLOGY

Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study

verfasst von: Valentina Gallo, Nicola Vanacore, H. Bas Bueno-de-Mesquita, Roel Vermeulen, Carol Brayne, Neil Pearce, Petra A. Wark, Heather A. Ward, Pietro Ferrari, Mazda Jenab, Peter M. Andersen, Patrik Wennberg, Nicholas Wareham, Verena Katzke, Rudolf Kaaks, Elisabete Weiderpass, Petra H. Peeters, Amalia Mattiello, Valeria Pala, Aurelio Barricante, Maria-Dolores Chirlaque, Noémie Travier, Ruth C. Travis, Maria-Jose Sanchez, Hélène Pessah-Rasmussen, Jesper Petersson, Anne Tjønneland, Rosario Tumino, Jose Ramon Quiros, Antonia Trichopoulou, Andreas Kyrozis, Despoina Oikonomidou, Giovanna Masala, Carlotta Sacerdote, Larraitz Arriola, Heiner Boeing, Matthaeus Vigl, Francoise Claver-Chapelon, Lefkos Middleton, Elio Riboli, Paolo Vineis

Erschienen in: European Journal of Epidemiology | Ausgabe 3/2016

Abstract

Previous case–control studies have suggested a possible increased risk of Amyotrophic Lateral Sclerosis (ALS) with physical activity (PA), but this association has never been studied in prospective cohort studies. We therefore assessed the association between PA and risk of death from ALS in the European Prospective Investigation into Cancer and Nutrition. A total of 472,100 individuals were included in the analysis, yielding 219 ALS deaths. At recruitment, information on PA was collected thorough standardised questionnaires. Total PA was expressed by the Cambridge Physical Activity Index (CPAI) and analysed in relation to ALS mortality, using Cox hazard models. Interactions with age, sex, and anthropometric measures were assessed. Total PA was weakly inversely associated with ALS mortality with a borderline statistically significant trend across categories (p = 0.042), with those physically active being 33 % less likely to die from ALS compared to those inactive: HR = 0.67 (95 % CI 0.42–1.06). Anthropometric measures, sex, and age did not modify the association with CPAI. The present study shows a slightly decreased—not increased like in case–control studies—risk of dying from ALS in those with high levels of total PA at enrolment. This association does not appear confounded by age, gender, anthropometry, smoking, and education. Ours was the first prospective cohort study on ALS and physical activity.

Introduction

Amyotrophic Lateral Sclerosis (ALS) is a progressive motor disease characterised by degeneration of the upper and lower motor neurons, with a median survival of 3 years [1]. Cigarette smoking is the only environmental factor which has been shown to increase the risk for this disease in case–control and cohort studies with solid design [25].
The observation that ALS incidence in Italy was increased among football players [6], recently reproduced in USA among American Football players [7], is consistent with the hypothesis, among others, that intense physical activity (PA) could be a risk factor for developing ALS. This hypothesis was firstly prompted by a US case–control study showing an increased risk of ALS among people who reported having participated in organised sports in high school [8]. It is supported by another small pilot case–control study from the USA showing an increased risk of ALS among those reporting more leisure-time PA, and those sweating while working [9]; by a more recent large population-based case–control study showing that leisure-time (but not occupational or vigorous) physical activity was associated with ALS (although there was not a clear dose–response relationship) [10]; and by a large population-based case–control study in Japan showing doubled risk of ALS among those practicing vigorous physical activity compared to physically inactive [11]. Conversely, a previous Dutch case–control study did not observe an association between PA and ALS: there was a younger age of symptom onset among those with a higher cumulative leisure PA [12]; although this was potentially explained by a birth cohort effect [13]. A very recent large case–control study found an inverse association between physical activity and ALS [14]. The main epidemiological observations to date on physical activity and ALS are summarised in Table 1.
Table 1
Summary of current epidemiological evidence investigating the association between physical activity and Amyotrophic Lateral Sclerosis
References
Setting
Study design
Sample
Main association
Confounders
Pupillo et al. [14]
Europe
Population-based case–control study
652 ALS cases and 1166 controls
Total PA
OR 0.65 (0.48–0.89)
Models adjusted for age, education, BMI, register, interview, traumatic events, coffee, alcohol, smoking, and work-related PA
Yu et al. [15]a
Michigan (USA)
Case–control study (controls recruited through health-related website)
66 ALS cases and 66 matched controls (sex and age)
High PA intensity in the past 30 years OR 5.98 (0.38–93.3)
 
Gotkine et al. [16]b
Jerusalem, Israel
Comparison of self-reported exposure to Triathlon in a case series with nationwide number of participants in the total population
185 cases of ALS and total Israeli population in 2011 (3,493,700)
OR for participation in triathlon 16.2 (5.6–36.4)
Huisman et al. [10]c
The Netherlands
Population-based case–control study
636 ALS cases and 2166 controls
Total PA adjusted OR 1.02 (0.98–1.06)
Leisure time PA OR 1.08 (1.02–1.14)
Occupational PA OR 1.00 (0.96–1.04)
Vigorous PA OR 1.24 (0.96–1.61)
Models adjusted for gender, age, BMI, current smoking, current alcohol consumption, and level of education
Lehman et al. [7]
USA
Standardised mortality ratios among professional American Football players
7 ALS deaths among 3439 American football players
SMR 4.31 (1.73–8.87)
 
Vanacore et al. [17]
USA
Case–control study on the US mortality dataset
14,628 ALS deaths and 58,512 matched controls (age, gender and geographic area)
OR for intense PA at work 0.95 (99 % CI 0.86–1.04) in men and 1.00 (99 % CI 0.82–1.20) in women
 
Chio’ et al. [18]d
Italy
Standardised mortality ratios among football, basketball player and road cyclist
8 ALS cases among 7325 football players; no ALS cases among 1973 basketball players and 1701 road cyclists
SMR for football players 6.45 (95 % CI 2.78–12.70)
 
Okamoto et al. [11]
Japan
Population-based case control study
183 ALS cases and 366 matched controls (age and gender)
Vigorous physical activity OR 2.0 (95 % CI 1.0–4.0)
Age, sex, bone fracture, “hate to lose personality”, self-reported stress, type A personality, smoking, alcohol, intake of green/yellow vegetables
Chio’ et al. [6]
Italy
Standardised mortality ratios among football players
5 ALS cases among 7325 football players
SMR 6.5 (95 % CI 2.1–15.1)
 
Valenti et al. [19]
Italy
Population-based case–control study
300 ALS cases and 300 matched controls (age and sex)
Any sport OR 0.38 (95 % CI 0.25–0.58)
 
Veldink et al. [12]
Netherlands
Case–control study (cases chose their own controls)
219 ALS cases and 254 controls
Cumulative occupational PA OR 4th versus 1st quartile 1.07 (estimated 95 % CI 0.9–4.0)
Cumulative leisure PA OR 4th versus 1st quartile 0.8 (estimated 95 % CI 0.6–1.8)
Sex, age, level of education, smoking, alcohol use, and premorbid body mass index (BMI)
Scarmeas et al. [20]
New York (USA)
Hospital-based case–control study (controls with other neurological diseases)
431 ALS cases and 152 controls (but analyses based on smaller numbers)
Varsity athlete
OR 1.89 (95 % CI 1.05–3.40)
Based on 232 cases and 121 controls
Age, sex, always slim, BMI
Longstreth et al. [8]
Washington (USA)
Washington state
Population-based case–control study
174 ALS cases and 348 matched controls (sex and age)
Lifetime PA in the workplace OR 3rd versus 1st tertile 1.07 (95 % CI 0.57–2.03)
Lifetime leisure PA OR 3rd versus 1st tertile 1.46 (95 % CI 0.89–2.39)
Participation in organised sports during high school OR 1.52 (95 % CI 1.03–2.25)
Education
Strickland et al. [9]
Minnesota (USA)
Semi-population-based semi-hospital-based case–control study
25 ALS cases and 50 controls: 25 hospital-based and 25 population-based
Having received recognition for organised sport participation at school OR 30 (95 % CI 1.04–9.30)
How often did PA case you to sweat at work in your twenties OR for trend across 5 categories 1.60 (95 % CI 1.1–2.4)
How often did you sweat during leisure time PA in your twenties OR for trend across 5 categories 1.60 (95 % CI 1.1–2.5)
 
aSingle sports (jogging/running, cycling, swimming, aerobic dancing, recreational dancing, calisthenics, gardening, weightlifting, soccer, football, baseball, field hockey, golf, ice hockey, tennis, boxing, wrestling) also tested yielding to non-significant differences between cases and controls
bSevere flaws in the study as the study design is not appropriate and prevalence of triathlon in the general population is likely to be overestimated (ever registered with the triathlon association)
cNone of the variables were associated with ALS survival
dData on football players are an update of the study published on Brain 2005; 128: 472–476
Hypotheses other than that of an association between PA and ALS which are indicated by the evidence produced so far include: (1) that participating in sports (and not PA per se) can increase the risk of ALS (for example via repeated head or limb traumas, or ingestion of illicit substances enhancing sportive performance); or (2) that the age when physical activity is undertaken modifies the risk of ALS. On the other hand, being lean and athletic might be a phenotypic expression of genetic susceptibility to ALS; this might be supported by the finding that cardiovascular fitness was found to be associated with ALS in a record linkage study [21]. To our knowledge, the association between PA and risk of ALS has never been investigated in a prospective study.
In a recent report from the EPIC cohort, a lower body mass index (BMI) in men and a lower waist-to-hip ratio (WHR) in women were associated with an increased risk of dying from ALS [22]. Similar results of a decreased risk in both men and women with increased BMI were recently reported in five US cohorts [23]. To what extent this association is modified by PA has not been explored so far.
The aims of this study are to: (1) assess the association between total PA and risk of death from ALS in the European Prospective Investigation into Cancer and Nutrition (EPIC); (2) explore the contribution of other cumulative measures of PA (occupational, household, recreational, potentially traumatic, practising sports, and vigorous PA) on the risk of ALS; and (3) investigate to what extent these associations are confounded or modified by anthropometric measures or other factors (sex and age).

Methods

Participants

The EPIC study was approved by the ethical committee of the International Agency for Research on Cancer (IARC) and by the ethics committees of each participating centre; all participants signed an informed consent. Ninety-one percent of the 518,408 participants were aged 35–70 years and were recruited from the general population residing in defined geographical areas between 1992 and 2002, in 23 centres across 10 Western European countries (Norway, Sweden, Denmark, United Kingdom, Netherlands, Germany, France, Spain, Italy, and Greece) [24]. Exceptions were the French cohort (based on women members of the health insurance for state school), the Ragusa (Italy) cohort (based on blood donors and their spouses), the Utrecht (Netherlands) and Florence (Italy) cohorts (based on breast cancer screening participants), and part of the Oxford (UK) cohort (based on vegetarians and vegans) [24]. The Norway, France, Naples (Italy), and Utrecht cohorts were restricted to women.
At recruitment, information on lifestyle and dietary habits was collected through standardised questionnaires and anthropometric characteristics were measured. Follow-up for mortality and specific causes of death is carried out actively or through linkage with mortality registries at regional and national levels [24]. To date, follow-up is 98.5 % complete. The Norwegian EPIC sub-cohort (n = 37,185) was excluded from the present analysis because it did not give rise to any ALS cases, given its younger age composition.
Information on mortality and causes of death was collected independently: follow-up time was censored in case of dropout, loss of follow-up or fatal events other than ALS death (whichever occurred first). Each EPIC centre had a different last date of follow-up, based on when a drop in the number of reported causes of death was observed, for minimising false negatives [22]. This resulted in censoring follow-up time at some stage between June 2005 and June 2009, generating 5,815,773 person-years for 472,100 subjects after excluding 9123 (1.9 %) individuals with missing data on exposure or confounding variables.

Case ascertainment

ALS cases were defined as those subjects for whom “motor neuron disease” (G12.2 according to the 10th revision of the International Statistical Classification of Diseases, Injuries and Causes of Death) was reported as an immediate, antecedent or underlying cause of death (for more details, see [2]).

Physical activity assessment

The assessment of PA measures is described in detail elsewhere [24, 25]. In brief, participants replied to a questionnaire at baseline about occupational PA, and recreational PA, including duration and frequency of walking, cycling, gardening (average values in summer and winter), household work, do-it-yourself (DIY) activities, and sports during the previous year.
Total PA was investigated using the Cambridge Physical Activity Index (CPAI), which combines occupational PA (sedentary occupation, standing occupation, manual/heavy manual work) with time participating in sports and spent cycling [26]. The total hours per week spent cycling or participating in sports was categorised in four levels (no, ≤3.5 h/week; >3.5 and ≤7.0 h/week; >7.0 h/week); based on a 4 × 4 matrix, participants were then classified in four final categories: inactive (sedentary job, no leisure time PA); moderately inactive (standing occupation and no leisure time PA or sedentary occupation and ≤3.5 h/week of leisure time PA); moderately active (manual occupation and no leisure time PA, or standing occupation and ≤3.5 h/week of leisure time PA, or sedentary occupation and >3.5 but ≤7 h/week of leisure time PA): and active (sedentary job with >7 h/week of leisure time PA, or standing job and >3.5 h/week of leisure time PA, or manual job and any leisure time PA, or heavy manual job) [26]. The index was developed by comparing the EPIC PA questionnaire with objective measures of cardio-respiratory fitness and energy expenditure assessed by heart-rate monitoring with individual calibration (measures validated against gold standard techniques) [26], and recently revalidated against a brief questionnaire examining energy expenditure and time spent in moderate and vigorous physical activity [27].
Information on housework, DIY, gardening and climbing stairs was combined to estimate the overall amount of household activity. Recreational PA included walking, cycling, gardening, sports, and DIY. Potentially traumatic PA was defined as performing manual or heavy manual work, playing sport, or doing DIY. Duration and frequency were directly estimated, and intensity (i.e. energy expenditure) was estimated by assigning metabolic equivalents (METs), ranging from 3 for walking and household activities to 6 for sports [28]. Household and recreational PA were categorised in quartiles of distribution; playing sports was categorized as 0, <12 (below the median) or 12+ (above the median) MET-h/week; vigorous PA was categorized as 0, ≤2 (below the median), or >2 (above the median) h/week; potentially traumatic PA was classified as ever/never.

Statistical analysis

Cox proportional hazard models, with age as the main time variable were used to investigate the associations between type and amount of PA and ALS mortality. Hazard ratio (HR) estimates were derived for the entire sample, stratified by age and centre of recruitment. Potential confounders included sex, highest level of education attained (none/primary, technical, secondary, university, undetermined), a composite smoking variable (never smoker, former smoker ≥10 years prior to enrolment; former smoker <10 years prior to enrolment, current smoker 1–4 cigarettes/day; 5–14 cigarettes/day, 15–24 cigarettes/day, ≥25 cigarettes/day, undetermined), BMI in units (kg/m2) and WHR. This composite smoking variable best takes into account the complex pattern of smoking variables on ALS risk found in this cohort [22].
For each Cox regression analysis, a p value for linear trend across categories was calculated by introducing the ordinal variable in the model. The p value for interaction between each PA category and sex, age (<50 years and 50+ years), BMI, and WHR was estimated using the log-likelihood ratio test comparing models with and without the interaction term (allowance made for p < 0.100). To further explore to what extent anthropometric measures could act as confounders separate models were computed: (1) including and excluding them; and (2) stratified by BMI categories [under/normal weight (<25.0 kg/m2), overweight (25.0–29.9 kg/m2), and obese (≥ 30 kg/m2)] and WHR sex-specific quartiles. To explore the extent to which PA modifies the age of ALS onset, the analysis of each PA variable was repeated among those with an age of death from ALS <70 years (N = 120), and among those aged 70+ years (N = 102).
A sensitivity analysis was conducted with models excluding ALS cases arising during the first 3 years of follow-up in order to minimise the potential for reverse causation. Statistical significance was set at 5 % for two-tailed tests.

Results

The characteristics of the cohort participants by the CPAI are described in Table 2.
Table 2
Demographic and lifestyle characteristics of the cohort according to categories of physical activity (n = 472,100)
 
Inactive
N = 109,545
Moderately inactive
N = 161,906
Moderately active
N = 113,854
Active
N = 86,795
Gender
Men, N (%)a
29,501 (26.9)
46,110 (28.5)
36,309 (31.9)
36,315 (41.8)
Women, N (%)a
80,044 (73.1)
115,796 (71.5)
77,545 (68.1)
50,480 (58.2)
Age (years), mean (SD)
55.2 (10.6)
51.8 (9.9)
49.8 (10.0)
47.9 (12.2)
Smoking b,c
Never
58,513 (54.2)
83,126 (52.2)
56,715 (50.7)
38,598 (44.9)
Former ≥10 years
17,003 (15.8)
28,405 (17.8)
21,147 (18.9)
17,411 (20.3)
Former <10 years
8535 (7.9)
14,269 (9.0)
10,461 (9.4)
8912 (10.4)
Current 1–4 cig/day
2200 (2.0)
4103 (2.6)
3009 (2.7)
2542 (3.0)
Current 5–14 cig/day
7406 (6.9)
10,953 (6.9)
7671 (6.9)
6748 (7.9)
Current 15–24 cig/day
8661 (8.0)
11,394 (7.2)
7812 (7.0)
7309 (8.5)
Current 25+ cig/day
5607 (5.2)
7086 (4.5)
5108 (4.6)
4457 (5.2)
BMI
Under-/normal weightb
44,599 (40.7)
85,665 (52.9)
64,251 (56.4)
46,191 (53.2)
Overweight
41,731 (38.1)
55,710 (34.4)
37,227 (32.7)
31,151 (35.9)
Obese
23,215 (21.2)
20,531 (12.7)
12,376 (10.9)
9453 (10.9)
Education b,d
None/primary
48,254 (46.6)
44,127 (28.3)
28,557 (25.9)
25,043 (29.6)
Technical
17,768 (17.1)
32,871 (21.1)
24,167 (21.9)
24,826 (29.4)
Secondary
18,272 (17.6)
34,953 (22.4)
25,134 (22.8)
14,673 (17.4)
University
19,340 (18.7)
44,210 (28.3)
32,526 (29.5)
19,976 (23.6)
ALS cases
72 (0.07)
80 (0.05)
38 (0.003)
29 (0.03)
aPercentages in rows; b percentages in column; c smoking status unknown for 6939 individuals (1.5 %); d unknown for 17,403 individuals (3.7 %)
A total of 219 ALS deaths (76 men and 143 women) arose during follow-up, with the mean follow-up period being 13 years (SD 3 years). Men and younger people were more likely to be physically active; a moderate association between higher levels of PA and higher educational level, lower BMI, and less smoking was observed (Table 2).
Total PA as estimated by the CPAI was inversely associated with ALS mortality, with a statistically significant trend across categories (p = 0.042) in the fully adjusted model (Table 3). Introducing BMI into the model, the statistical significance of the linear trend was maintained (p = 0.032), and risk estimates were slightly strengthened (p value for the interaction with BMI = 0.318); replacing BMI with WHR, the risk estimates were slightly reduced as was the significance level of the linear trend (p = 0.084) (p value for the interaction with WHR = 0.889). Hazard ratio estimates by BMI categories and WHR quartiles are shown in Fig. 1.
Table 3
HR of dying from ALS according to type of physical activity
 
ALS cases
Adjusted HR (95 % CI)a
Adjusted HR (95 % CI)a including BMI
Adjusted HR (95 % CI)a including WHR
Cambridge index of physical activity
Inactive
72 (32.9)
1.00 (ref)
1.00 (ref)
1.00 (ref)
Moderately inactive
80 (36.5)
0.88 (0.63–1.22)
0.86 (0.62–1.20)
0.92 (0.64–1.34)
Moderately active
38 (17.4)
0.70 (0.46–1.05)
0.68 (0.45–1.03)
0.76 (0.48–1.20)
Active
29 (13.2)
0.67 (0.42–1.06)
0.65 (0.41–1.04)
0.67 (0.40–1.11)
p-trend
 
0.042
0.032
0.084
Occupational activity
Sedentary
28 (35.4)
1.00 (ref)
1.00 (ref)
1.00 (ref)
Standing
34 (43.0)
1.39 (0.83–2.35)
1.39 (0.83–2.35)
1.73 (0.97–3.09)
Manual/heavy manual
17 (21.5)
1.28 (0.67–2.44)
1.28 (0.67–2.43)
1.61 (0.80–3.24)
p-trend
 
0.341
0.343
0.113
Household activity
1st quartile
42 (20.0)
1.00 (ref)
1.00 (ref)
1.00 (ref)
2nd quartile
69 (32.9)
1.43 (0.97–2.11)
1.43 (0.97–2.11)
1.77 (1.11–2.78)
3rd quartile
42 (20.0)
0.82 (0.52–1.27)
0.81 (0.52–1.27)
0.94 (0.57–1.56)
4th quartile
57 (27.1)
1.11 (0.72–1.70)
1.11 (0.73–1.71)
1.25 (0.77–2.02)
p-trend
 
0.649
0.662
0.795
Recreational activity
1st quartile
46 (21.9)
1.00 (ref)
1.00 (ref)
1.00 (ref)
2nd quartile
56 (26.7)
1.06 (0.71–1.57)
1.05 (0.70–1.55)
1.07 (0.70–1.63)
3rd quartile
59 (28.1)
1.15 (0.77–1.70)
1.13 (0.76–1.67)
0.93 (0.60–1.45)
4th quartile
49 (23.3)
0.91 (0.60–1.39)
0.89 (0.59–1.36)
0.83 (0.53–1.31)
p-trend
 
0.770
0.688
0.328
Practising sports
No
131 (29.8)
1.00 (ref)
1.00 (ref)
1.00 (ref)
Below the median
36 (16.4)
0.85 (0.58–1.24)
0.84 (0.57–1.23)
0.82 (0.54–1.25)
Above the median
52 (23.7)
1.03 (0.74–1.44)
1.01 (0.72–1.41)
1.01 (0.70–1.45)
p-trend
 
0.985
0.921
0.899
Potentially traumatic physical activity
Never
90 (41.1)
1.00 (ref)
1.00 (ref)
1.00 (ref)
Ever
129 (58.1)
0.93 (0.69–1.26)
0.92 (0.67–1.24)
0.91 (0.65–1.26)
Vigorous physical activity
None
96 (60.4)
1.00 (ref)
1.00 (ref)
1.00 (ref)
≤2 h/week
39 (24.5)
1.16 (0.77–1.75)
1.15 (0.77–1.74)
1.05 (0.65–1.68)
>2 h/week
24 (15.1)
0.89 (0.55–1.43)
0.89 (0.55–1.43)
0.93 (0.55–1.57)
p-trend
 
0.789
0.769
0.833
aModel stratified by centre and age and adjusted for smoking status, highest level of education attained, and sex
The association between CPAI and ALS mortality did not appear to be modified by gender (p interaction = 0.272) or age (p interaction = 0.875). When the main analysis was repeated after excluding those who were unemployed at recruitment (34.7 %) (and thus a priori classified as in a sedentary job occupation), the association between CPAI and ALS remained of similar magnitude although falling short of statistical significance due to the reduction of the sample size (ALS cases = 147).
Occupational, household, recreational, potentially traumatic, sportive, and vigorous PAs were not associated with ALS mortality (Table 3). Although this sample is not powered to allow subgroup analyses, we obtained suggestive results for two interactions. The association with practising sports appeared modified by anthropometry: those normal weight practising sports above the median had a HR 0.77 (95 % CI 0.47–1.26) compared to those who did not practice any sport, those overweight a HR 1.30 (0.77–2.20), and those obese a HR 1.56 (0.63–3.87) (p value for interaction with BMI 0.098); subjects in each quartile of WHR had a HR 0.53 (0.23–1.22), HR 0.82 (0.38–1.76), HR 1.08 (0.56–2.09), and HR 2.15 (1.08–4.31) respectively comparing those practising sport above the median versus those not practicing sports (p value for interaction with WHR 0.045). These findings were not statistically significant, possible due to small numbers; the association with ALS appears to reverse if sports were practised by obese people (Fig. 2). The association with vigorous PA appeared to be modified by age at recruitment (thus age when the exposure was assessed) (p value for interaction = 0.048): despite the reduced sample size (ALS cases = 31), there was a suggestion of a positive association among those reporting vigorous activity early in life (<50 years) HR = 3.20 (95 % CI 0.87–11.74) for ≤2 h/week; and HR = 3.37 (95 % CI 0.88–12.93) for >2 h/week); p value for trend across categories 0.070). This association was not present among those reporting vigorous PA later on [HR = 1.04 (95 % CI 0.67–1.62); HR = 0.74 (95 % CI 0.44–1.26), respectively]. Models run separately for early and late age of ALS onset showed effect estimates comparable to those of the main analysis in both categories (results not shown).
The sensitivity analysis involving models excluding ALS cases arising during the first 3 years and during the first 5 years of follow-up showed a stronger inverse association between the CPAI and risk of dying from ALS [compared to the inactive, HR for the moderately inactive = 0.79 (95 % CI 0.56–1.12); HR for moderately active = 0.60 (95 % CI 0.39–0.93); and HR for the active = 0.65 (95 % CI 0.40–1.05), p for linear trend = 0.027 after excluding cases arisen during the first 3 years of follow up (N = 197); the same estimates after excluding cases arisen during the first 5 years of follow-up are HR = 0.69 (95 % CI 0.47–1.02); HR = 0.55 (95 % CI 0.34–0.90); and HR = 0.70 (95 % CI 0.42–1.16), p for linear trend = 0.067 (n = 162)]. All other results were substantially unchanged, apart from the widening of the confidence intervals due to the reduction of sample size.

Discussion

The present study shows a borderline significant inverse dose–response relationship between total PA measured at enrolment and subsequent risk of dying from ALS. This association does not appear to be confounded or modified by age, gender, or BMI, smoking, or highest level of education attained; but it became of borderline statistical significance once introducing WHR into model. The CPAI was designed for ranking the participants according to their overall PA based on heart rate monitoring, best reflecting the amount of energy spent in physical activities [26].
This is the first prospective cohort study assessing the type and amount of PA before disease onset, and the subsequent risk of developing and dying from ALS. The finding of an inverse association between PA and risk of ALS is at odds with the majority of findings coming from case–control studies [8, 10, 12, 20].
To date, in fact, all published evidence on the association between ALS and PA comes either from case–control studies [8, 9, 20, 29], or from retrospective cohort studies [6, 7]. The former have the limitation of being prone to recall bias (which might be particularly relevant when assessing PA whose quantification is not easy, and which can be easily related by patients to a disease impairing movements). The retrospective cohort studies investigating the risk of ALS among football players have the advantage of including large numbers, but are limited to a highly selected group, and cannot fully account for potential confounders.
Possible ways in which PA may increase the risk of ALS involve oxidative stress, glutamate excitotoxicity and complex interactions with ALS susceptibility genes [30]. On the other hand, the mechanisms through which PA might protect against ALS are thought to be mediated by exercise-induced changes in motor neuron morphology, muscle-nerve interaction, glial activation, and altering levels of gene expression of anti-apoptotic proteins and neurotrophic factors [31]. The effects of exercise upon astrocytes and angiogenesis are also relevant in ALS as astrocytes play an important structural role in the maintenance of the blood–brain barrier (BBB) [32]. A disruption of the BBB in SOD1 mice was found starting in the early stages of the disease [33]. The extensive disruption of the neurovascular unit may promote the progressive loss of motor neurons, with their integrity dependent upon efficient capillary influx of nutrients and efflux of waste, as well as direct supportive interactions with astrocytes. In the brains of exercised rats, the neurovascular unit is strengthened by increased angiogenesis and astrocyte proliferation [34].
The present data suggest that reverse causality is not a likely explanation of the results: after removing ALS deaths during the first 3 years of follow up, the inverse association strengthened (albeit with a reduced sample size). The role of unemployment in contributing to the CPAI is more complex: it might represent an effect of residual confounding of socio-economic status, or an unmeasured reverse causality. However, the fact that an association of similar magnitude between CPAI and ALS mortality (albeit not significant) is obtained after excluding those subjects who were unemployed at recruitment suggests that residual confounding or reverse causality are perhaps not the most likely explanations.
The present study had lower statistical power to detect interactions, and the findings in this sense should be interpreted cautiously and regarded as hypothesis generating. Nevertheless, it is interesting that there was also a suggestion of an increased risk of ALS from vigorous PA in obese subjects (or subjects with an elevated BMI due to substantial increase of muscle mass) among those practising sports, and in young individuals. Should these be confirmed by further investigations, they may reflect some specific characteristics of these two categories, such as, for example, the use of some stimulating agents enhancing sportive performance and/or promoting weight loss [35]. Some of these compounds, such as anabolic steroids and testosterone, increasingly used and abused by athletes for enhancing performance [36], have been shown to stimulate muscle mass increase [37]. These hormones may increase ALS risk though unknown mechanisms, and may also contribute to the higher incidence of ALS in men than women [38]. This hypothesis is consistent with previous observations linking ALS risk to practising sports in general [17, 20], or being professional football players [6, 7], or varsity athletes [8, 9, 20] or professional athletes [17]. Also, a recent report from Europe describes an inverse association between PA and ALS, except for professional sport players [29, 39]. Unfortunately, we are not able to reproduce the findings on professional sport players in this setting, as this information is not available in EPIC. A cohort effect explaining the suggested increased risk among those practising vigorous PA at younger ages has already been suggested by Ascherio [13] in reference to the study by Veldink et al. [12]; this cannot be ruled out, although it seems an unlikely explanation given that it applies to vigorous activity only. The small sample size and the relative oversampling of women by design in the EPIC study do not allow powered estimates of association in both sexes, separately. Despite the p value for interaction with sex being far non-significant (p = 0.272), we cannot rule out that the present results are at least partially driven by the association in women.
Death records appear to be reliable for ascertaining ALS deaths (and hence ALS itself) in this [2] and other large population studies [40]. Nonetheless, a recent study in UK identified an error in the WHO ICD-10 Alphabetic coding Index where progressive supranuclear palsy was mistakenly given as code G12 [23]. However, a validation exercise on death records demonstrated that only 8 % of the women receiving a diagnosis of ALS were misclassified [3]. Furthermore, misclassification introduced by the use of death records instead of specialist diagnoses would likely be non-differential and thus bias the estimate towards the null; therefore the risk estimates reported here might underestimate true associations.
In summary, in this prospective study, practising more PA was associated with a reduced risk of dying from ALS. This association does not appear to be confounded or modified by age, gender, BMI, smoking and the highest level of education attained, and it is unlikely explained by reverse causation.

Acknowledgments

This research has been made possible thanks to a grant of the European Community (5th Framework Programme) to Prof. Paolo Vineis (Grant QLK4CT199900927); and a grant of the Compagnia di San Paolo to the ISI Foundation. All authors are independent form founders. Mortality data from the Netherlands are obtained from “Statistics Netherlands”. In addition we would like to thank for their financial support: Europe Against cancer Program of the European Commission (SANCO); ISCIII, Red de Centros RCESP, C03/09; Spanish Ministry of Health (ISCIII RETICC RD06/0020); Deutsche Krebshilfe; Deutsches Krebsforschungszentrum; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health; Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; Spanish Ministry of Health (ISCIII RETICC RD06/0020)Cancer Research UK; Medical Research Council, United Kingdom; Stroke Association, United Kingdom; British Heart Foundation; Department of Health, United Kingdom; Food Standards Agency, United Kingdom; Wellcome Trust, United Kingdom Greek Ministry of Health; Greek Ministry of Education; Italian Association for Research on Cancer (AIRC); Italian National Research Council; Dutch Ministry of Public Health, Welfare and Sports (VWS); Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF); Statistics Netherlands (The Netherlands); Swedish Cancer; Swedish Scientific Council; Regional Government of Skåne and Västerbotten, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against cancer, Inserm, Mutuelle Generale l’Education National and IGR.

Author contributions

Dr. Gallo had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: H. Bas Bueno-de-Mesquita, Nicholas Wareham, Rudolf Kaaks, Petra P Peeters, Amalia Mattiello, Valeria Pala, Aurelio Barricante, Maria-Dolores Chirlaque, Ruth C. Travis, Anne Tjønneland, Rosario Tumino, Jose’ Ramon Quiros, Antonia Trichopoulou, Giovanna Masala, Carlotta Sacerdote, Heiner Boeing, Francoise Claver-Chapelon, Elio Riboli, Paolo Vineis. Analysis and interpretation of data: Valentina Gallo, Nicola Vanacore, H. Bas Bueno-de-Mesquita, Roel Vermeulen, Carol Brayne, Petra A. Wark, Heather A Ward, Pietro Ferrari, Mazda Jenab, Peter Andersen. Drafting of the manuscript: Valentina Gallo, Nicola Vanacore, Paolo Vineis. Data collection: H. Bas Bueno-de-Mesquita, Roel Vermeulen, Pietro Ferrari, Mazda Jenab, Nicholas Wareham, Verena Grote, Rudolf Kaaks, Elisabete Weiderpass, Petra P Peeters, Amalia Mattiello, Valeria Pala, Aurelio Barricante, Maria-Dolores Chirlaque, Noémie Travier, Ruth C. Travis, Maria-Jose Sanchez, Hélène Pessah-Rasmussen, Jesper Petersson, Anne Tjønneland, Rosario Tumino, Jose’ Ramon Quiros, Antonia Trichopoulou, Andreas Kyrozis, Despoina Oikonomidou, Giovanna Masala, Carlotta Sacerdote, Larraitz Arriola, Heiner Boeing, Francoise Claver-Chapelon, Lefkos Middleton, Elio Riboli, Paolo Vineis. Critical revision of the manuscript for important intellectual content: H. Bas Bueno-de-Mesquita, Roel Vermeulen, Carol Brayne, Petra A. Wark, Heather A Ward, Pietro Ferrari, Mazda Jenab, Peter Andersen, Patrik Wennberg, Nicholas Wareham, Verena Grote, Rudolf Kaaks, Elisabete Weiderpass, Petra P Peeters, Amalia Mattiello, Valeria Pala, Aurelio Barricante, Maria-Dolores Chirlaque, Noémie Travier, Ruth C. Travis, Maria-Jose Sanchez, Hélène Pessah-Rasmussen, Jesper Petersson, Anne Tjønneland, Rosario Tumino, Jose’ Ramon Quiros, Antonia Trichopoulou, Andreas Kyrozis, Despoina Oikonomidou, Giovanna Masala, Carlotta Sacerdote, Larraitz Arriola, Heiner Boeing, Francoise Claver-Chapelon, Lefkos Middleton, Elio Riboli, Paolo Vineis.

Funding

The EPIC study is funded by a number of grants; however, no funding source had any role in the preparation of this manuscript.

Compliance with ethical standards

Conflict of interest

We declare that we have no conflict of interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Dent – Das Online-Abo der Zahnmedizin

Online-Abonnement

Mit e.Dent erhalten Sie Zugang zu allen zahnmedizinischen Fortbildungen und unseren zahnmedizinischen und ausgesuchten medizinischen Zeitschriften.

Literatur
1.
Zurück zum Zitat Armon C. Amyotrophic lateral sclerosis. In: Nelson LM, Tanner CM, Van Den Eeden SK, editors. Neuroepidemiology. From principle to practice. Oxford: Oxford University Press; 2004. p. 162–87. Armon C. Amyotrophic lateral sclerosis. In: Nelson LM, Tanner CM, Van Den Eeden SK, editors. Neuroepidemiology. From principle to practice. Oxford: Oxford University Press; 2004. p. 162–87.
2.
Zurück zum Zitat Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009;65(4):378–85.CrossRefPubMed Gallo V, Bueno-De-Mesquita HB, Vermeulen R, Andersen PM, Kyrozis A, Linseisen J, et al. Smoking and risk for amyotrophic lateral sclerosis: analysis of the EPIC cohort. Ann Neurol. 2009;65(4):378–85.CrossRefPubMed
3.
Zurück zum Zitat Doyle P, Brown A, Beral V, Reeves G, Green J. Incidence of and risk factors for motor neurone disease in UK women: a prospective study. BMC Neurol. 2012;12:25.CrossRefPubMedPubMedCentral Doyle P, Brown A, Beral V, Reeves G, Green J. Incidence of and risk factors for motor neurone disease in UK women: a prospective study. BMC Neurol. 2012;12:25.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat de Jong SW, Huisman MH, Sutedja NA, van der Kooi AJ, de Visser M, Schelhaas HJ, et al. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol. 2012;176(3):233–9.CrossRefPubMed de Jong SW, Huisman MH, Sutedja NA, van der Kooi AJ, de Visser M, Schelhaas HJ, et al. Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol. 2012;176(3):233–9.CrossRefPubMed
5.
Zurück zum Zitat Nelson LM, Matkin C, Longstreth WT Jr, McGuire V. Population-based case–control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol. 2000;151(2):164–73.CrossRefPubMed Nelson LM, Matkin C, Longstreth WT Jr, McGuire V. Population-based case–control study of amyotrophic lateral sclerosis in western Washington State. II. Diet. Am J Epidemiol. 2000;151(2):164–73.CrossRefPubMed
6.
Zurück zum Zitat Chio A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128(Pt 3):472–6.CrossRefPubMed Chio A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128(Pt 3):472–6.CrossRefPubMed
7.
Zurück zum Zitat Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79(19):1970–4.CrossRefPubMedPubMedCentral Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology. 2012;79(19):1970–4.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case–control study. Arch Neurol. 1998;55(2):201–6.CrossRefPubMed Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case–control study. Arch Neurol. 1998;55(2):201–6.CrossRefPubMed
9.
Zurück zum Zitat Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case–control study. Acta Neurol Scand. 1996;94(1):45–50.CrossRefPubMed Strickland D, Smith SA, Dolliff G, Goldman L, Roelofs RI. Physical activity, trauma, and ALS: a case–control study. Acta Neurol Scand. 1996;94(1):45–50.CrossRefPubMed
10.
Zurück zum Zitat Huisman MH, Seelen M, de Jong SW, Dorresteijn KR, van Doormaal PT, van der Kooi AJ, et al. Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013. Huisman MH, Seelen M, de Jong SW, Dorresteijn KR, van Doormaal PT, van der Kooi AJ, et al. Lifetime physical activity and the risk of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013.
11.
Zurück zum Zitat Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S, et al. Lifestyle factors and risk of amyotrophic lateral sclerosis: a case–control study in Japan. Ann Epidemiol. 2009;19(6):359–64.CrossRefPubMed Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S, et al. Lifestyle factors and risk of amyotrophic lateral sclerosis: a case–control study in Japan. Ann Epidemiol. 2009;19(6):359–64.CrossRefPubMed
12.
Zurück zum Zitat Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JH, van den Berg LH. Physical activity and the association with sporadic ALS. Neurology. 2005;64(2):241–5.CrossRefPubMed Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JH, van den Berg LH. Physical activity and the association with sporadic ALS. Neurology. 2005;64(2):241–5.CrossRefPubMed
13.
Zurück zum Zitat Ascherio A. Physical activity and the association with sporadic ALS. Neurology. 2005;65(6):972–3 (author reply 72–3). Ascherio A. Physical activity and the association with sporadic ALS. Neurology. 2005;65(6):972–3 (author reply 72–3).
14.
Zurück zum Zitat Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chio A, et al. Physical activity and amyotrophic lateral sclerosis: a European population-based case–control study. Ann Neurol. 2014;75(5):708–16.CrossRefPubMed Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chio A, et al. Physical activity and amyotrophic lateral sclerosis: a European population-based case–control study. Ann Neurol. 2014;75(5):708–16.CrossRefPubMed
15.
Zurück zum Zitat Yu Y, Su FC, Callaghan BC, Goutman SA, Batterman SA, Feldman EL. Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case–control study of ALS in Michigan. PLoS ONE. 2014;9(6):e101186.CrossRefPubMedPubMedCentral Yu Y, Su FC, Callaghan BC, Goutman SA, Batterman SA, Feldman EL. Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case–control study of ALS in Michigan. PLoS ONE. 2014;9(6):e101186.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Gotkine M, Friedlander Y, Hochner H. Triathletes are over-represented in a population of patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):534–6.CrossRefPubMed Gotkine M, Friedlander Y, Hochner H. Triathletes are over-represented in a population of patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7–8):534–6.CrossRefPubMed
17.
Zurück zum Zitat Vanacore N, Cocco P, Fadda D, Dosemeci M. Job strain, hypoxia and risk of amyotrophic lateral sclerosis: results from a death certificate study. Amyotroph Lateral Scler. 2010;11(5):430–4.CrossRefPubMed Vanacore N, Cocco P, Fadda D, Dosemeci M. Job strain, hypoxia and risk of amyotrophic lateral sclerosis: results from a death certificate study. Amyotroph Lateral Scler. 2010;11(5):430–4.CrossRefPubMed
18.
Zurück zum Zitat Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, Mora G. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10(4):205–9.CrossRefPubMed Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, Mora G. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph Lateral Scler. 2009;10(4):205–9.CrossRefPubMed
19.
Zurück zum Zitat Valenti M, Pontieri FE, Conti F, Altobelli E, Manzoni T, Frati L. Amyotrophic lateral sclerosis and sports: a case–control study. Eur J Neurol. 2005;12(3):223–5.CrossRefPubMed Valenti M, Pontieri FE, Conti F, Altobelli E, Manzoni T, Frati L. Amyotrophic lateral sclerosis and sports: a case–control study. Eur J Neurol. 2005;12(3):223–5.CrossRefPubMed
20.
Zurück zum Zitat Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59(5):773–5.CrossRefPubMed Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and varsity athletics in ALS. Neurology. 2002;59(5):773–5.CrossRefPubMed
21.
Zurück zum Zitat Turner MR, Wotton C, Talbot K, Goldacre MJ. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry. 2012;83(4):395–8.CrossRefPubMed Turner MR, Wotton C, Talbot K, Goldacre MJ. Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry. 2012;83(4):395–8.CrossRefPubMed
22.
Zurück zum Zitat Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80(9):829–38.CrossRefPubMedPubMedCentral Gallo V, Wark PA, Jenab M, Pearce N, Brayne C, Vermeulen R, et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: the EPIC cohort. Neurology. 2013;80(9):829–38.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat O’Reilly EJ, Wang H, Weisskopf MG, Fitzgerald KC, Falcone G, McCullough ML, et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(3):205–11.CrossRefPubMedPubMedCentral O’Reilly EJ, Wang H, Weisskopf MG, Fitzgerald KC, Falcone G, McCullough ML, et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(3):205–11.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113–24.CrossRefPubMed Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113–24.CrossRefPubMed
25.
Zurück zum Zitat Haftenberger M, Schuit AJ, Tormo MJ, Boeing H, Wareham N, Bueno-de-Mesquita HB, et al. Physical activity of subjects aged 50–64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2002;5(6B):1163–76.CrossRefPubMed Haftenberger M, Schuit AJ, Tormo MJ, Boeing H, Wareham N, Bueno-de-Mesquita HB, et al. Physical activity of subjects aged 50–64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2002;5(6B):1163–76.CrossRefPubMed
26.
Zurück zum Zitat Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2003;6(4):407–13.CrossRefPubMed Wareham NJ, Jakes RW, Rennie KL, Schuit J, Mitchell J, Hennings S, et al. Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2003;6(4):407–13.CrossRefPubMed
27.
Zurück zum Zitat Peters T, Brage S, Westgate K, Franks PW, Gradmark A, Tormo Diaz MJ, et al. Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol. 2012;27(1):15–25.CrossRefPubMed Peters T, Brage S, Westgate K, Franks PW, Gradmark A, Tormo Diaz MJ, et al. Validity of a short questionnaire to assess physical activity in 10 European countries. Eur J Epidemiol. 2012;27(1):15–25.CrossRefPubMed
28.
Zurück zum Zitat Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9 Suppl):S498–504.CrossRefPubMed Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000;32(9 Suppl):S498–504.CrossRefPubMed
29.
Zurück zum Zitat Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chio A, et al. Physical activity and ALS. A European population-based, case–control study. Ann Neurol. 2014. Pupillo E, Messina P, Giussani G, Logroscino G, Zoccolella S, Chio A, et al. Physical activity and ALS. A European population-based, case–control study. Ann Neurol. 2014.
30.
Zurück zum Zitat Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler. 2009;10(4):191–204.CrossRefPubMed Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler. 2009;10(4):191–204.CrossRefPubMed
31.
Zurück zum Zitat McCrate ME, Kaspar BK. Physical activity and neuroprotection in amyotrophic lateral sclerosis. NeuroMol Med. 2008;10(2):108–17.CrossRef McCrate ME, Kaspar BK. Physical activity and neuroprotection in amyotrophic lateral sclerosis. NeuroMol Med. 2008;10(2):108–17.CrossRef
32.
Zurück zum Zitat Abbott NJ, Ronnback L, Hansson E. Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci. 2006;7(1):41–53.CrossRefPubMed Abbott NJ, Ronnback L, Hansson E. Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci. 2006;7(1):41–53.CrossRefPubMed
33.
Zurück zum Zitat Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR. Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 2007;1157:126–37.CrossRefPubMed Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR. Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 2007;1157:126–37.CrossRefPubMed
34.
Zurück zum Zitat Li J, Ding YH, Rafols JA, Lai Q, McAllister JP 2nd, Ding Y. Increased astrocyte proliferation in rats after running exercise. Neurosci Lett. 2005;386(3):160–4.CrossRefPubMed Li J, Ding YH, Rafols JA, Lai Q, McAllister JP 2nd, Ding Y. Increased astrocyte proliferation in rats after running exercise. Neurosci Lett. 2005;386(3):160–4.CrossRefPubMed
35.
Zurück zum Zitat Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343(25):1833–8.CrossRefPubMed Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343(25):1833–8.CrossRefPubMed
37.
Zurück zum Zitat Storer TW, Magliano L, Woodhouse L, Lee ML, Dzekov C, Dzekov J, et al. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab. 2003;88(4):1478–85.CrossRefPubMed Storer TW, Magliano L, Woodhouse L, Lee ML, Dzekov C, Dzekov J, et al. Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension. J Clin Endocrinol Metab. 2003;88(4):1478–85.CrossRefPubMed
38.
Zurück zum Zitat Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942–55.CrossRefPubMed Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942–55.CrossRefPubMed
39.
Zurück zum Zitat Pupillo EBECA. Sport-related physical activity and amyotrophic lateral sclerosis. In: 3rd international conference of neurology and eidemiology. Nice, France; 2012. Pupillo EBECA. Sport-related physical activity and amyotrophic lateral sclerosis. In: 3rd international conference of neurology and eidemiology. Nice, France; 2012.
40.
Zurück zum Zitat Beghi E, Logroscino G, Micheli A, Millul A, Perini M, Riva R, et al. Validity of hospital discharge diagnoses for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(2):99–104.CrossRefPubMed Beghi E, Logroscino G, Micheli A, Millul A, Perini M, Riva R, et al. Validity of hospital discharge diagnoses for the assessment of the prevalence and incidence of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2(2):99–104.CrossRefPubMed
Metadaten
Titel
Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study
verfasst von
Valentina Gallo
Nicola Vanacore
H. Bas Bueno-de-Mesquita
Roel Vermeulen
Carol Brayne
Neil Pearce
Petra A. Wark
Heather A. Ward
Pietro Ferrari
Mazda Jenab
Peter M. Andersen
Patrik Wennberg
Nicholas Wareham
Verena Katzke
Rudolf Kaaks
Elisabete Weiderpass
Petra H. Peeters
Amalia Mattiello
Valeria Pala
Aurelio Barricante
Maria-Dolores Chirlaque
Noémie Travier
Ruth C. Travis
Maria-Jose Sanchez
Hélène Pessah-Rasmussen
Jesper Petersson
Anne Tjønneland
Rosario Tumino
Jose Ramon Quiros
Antonia Trichopoulou
Andreas Kyrozis
Despoina Oikonomidou
Giovanna Masala
Carlotta Sacerdote
Larraitz Arriola
Heiner Boeing
Matthaeus Vigl
Francoise Claver-Chapelon
Lefkos Middleton
Elio Riboli
Paolo Vineis
Publikationsdatum
11.03.2016
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 3/2016
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-016-0119-9

Weitere Artikel der Ausgabe 3/2016

European Journal of Epidemiology 3/2016 Zur Ausgabe